Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide cisplatin as first line treatment in patients ( pdf  

Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide cisplatin as first line treatment in patients ( pdf

Download
Use download accelerator + browser extension.

Size: 1.1 MB

Pages: 1

Date: 2011-03-30

Recommend this on Google
 

Comments (not logged in)

CAPTCHA refresh CAPTCHA

Latest comments:

 

Authorisation